Gupta Yashdeep, Kubihal Suraj, Kandasamy Devasenathipathy, Goyal Ankur, Goyal Alpesh, Kalaivani Mani, Tandon Nikhil
Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India.
Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
Indian J Endocrinol Metab. 2023 Jul-Aug;27(4):319-324. doi: 10.4103/ijem.ijem_60_23. Epub 2023 Aug 28.
This prospective longitudinal study aims to evaluate and compare the incidence of prediabetes/diabetes among women stratified at the baseline postpartum visit according to the prior GDM and NAFLD status.
Of the 309 women with baseline postpartum assessment at a median of 16 months following the index delivery, 200 (64.7%) [GDM: 137 (68.5%), normoglycaemia: 63 (31.5%)] were available for the follow-up analysis (performed at median of 54 months following the index delivery) and were participants for this study. We obtained relevant demographic, medical and obstetric details and performed a 75 g OGTT with glucose estimation at 0 and 120 min. NAFLD status was defined by ultrasonography at the baseline visit. Participants were divided into four groups: no NAFLD and no prior GDM (group 1), NAFLD but no prior GDM (group 2), prior GDM but no NAFLD (group 3), and NAFLD and prior GDM (group 4).
The mean age of study participants (n = 200) was 32.2 ± 5.1 years, and the mean interval between the two visits was 34.8 ± 5.5 months. A total of 74 (37%) women had progression to prediabetes/diabetes [incidence rate of 12.8/100 woman-years]. The incidence rates (per 100 woman-years) were 8.6, 8.9, 13.4 and 15.3 in groups 1, 2, 3 and 4, respectively. The adjusted hazard ratio for incident (new-onset) prediabetes/diabetes in group 4 (reference: group 1) was 1.99 (95% CI 0.80, 4.96, = 0.140). Among women with baseline NAFLD (irrespective of GDM status), the risk of incident prediabetes/diabetes increased with an increase in the duration of follow-up (3.03-fold higher per year of follow-up, = 0.029) and was significantly higher in women who were not employed (6.43, 95% CI 1.74, 23.7, = 0.005) and in women with GDM requiring insulin/metformin during pregnancy (4.46, 95% CI 1.27, 15.64, = 0.019).
NAFLD and GDM increased the risk for glycaemic deterioration in young Indian women. Future studies should focus on evaluating the effectiveness of lifestyle and behavioural interventions in such high-risk women.
本前瞻性纵向研究旨在评估并比较产后初次访视时根据既往妊娠糖尿病(GDM)和非酒精性脂肪性肝病(NAFLD)状态分层的女性中糖尿病前期/糖尿病的发病率。
在产后中位时间16个月进行基线评估的309名女性中,200名(64.7%)[GDM:137名(68.5%),血糖正常:63名(31.5%)]可用于后续分析(在产后中位时间54个月进行)并参与本研究。我们获取了相关的人口统计学、医学和产科详细信息,并进行了75克口服葡萄糖耐量试验(OGTT),分别于0分钟和120分钟测定血糖。NAFLD状态在基线访视时通过超声检查确定。参与者被分为四组:无NAFLD且无既往GDM(第1组)、有NAFLD但无既往GDM(第2组)、既往有GDM但无NAFLD(第3组)以及有NAFLD且既往有GDM(第4组)。
研究参与者(n = 200)的平均年龄为32.2±5.1岁,两次访视之间的平均间隔为34.8±5.5个月。共有74名(37%)女性进展为糖尿病前期/糖尿病[发病率为12.8/100女性年]。第1、2、3和4组的发病率(每100女性年)分别为8.6、8.9、13.4和15.3。第4组(参照:第1组)新发糖尿病前期/糖尿病的调整后风险比为1.99(95%置信区间0.80,4.96,P = 0.140)。在基线时有NAFLD的女性中(无论GDM状态如何),新发糖尿病前期/糖尿病的风险随随访时间的增加而增加(随访每增加一年,风险高3.03倍,P = 0.029),且在未就业女性中显著更高(6.43,95%置信区间1.74,23.7,P = 0.005),在孕期需要胰岛素/二甲双胍治疗的GDM女性中也显著更高(4.46,95%置信区间1.27,15.64,P = 0.019)。
NAFLD和GDM增加了年轻印度女性血糖恶化的风险。未来的研究应侧重于评估针对此类高危女性的生活方式和行为干预措施的有效性。